IXICO (LON:IXI) Share Price Crosses Below Two Hundred Day Moving Average – What’s Next?

IXICO plc (LON:IXI)’s stock price passed below its 200-day moving average during trading on Thursday . The stock has a 200-day moving average of GBX 8.42 and traded as low as GBX 7.50. IXICO shares last traded at GBX 8.45, with a volume of 14,599 shares traded.

IXICO Stock Performance

The company has a market cap of £18.50 million, a price-to-earnings ratio of -4.33, a price-to-earnings-growth ratio of -0.38 and a beta of 0.13. The stock’s fifty day simple moving average is GBX 8.50 and its two-hundred day simple moving average is GBX 8.42. The company has a debt-to-equity ratio of 5.22, a quick ratio of 4.90 and a current ratio of 2.83.

IXICO (LON:IXI) last announced its quarterly earnings data on Tuesday, May 19th. The company reported GBX (1.21) earnings per share (EPS) for the quarter. The company had revenue of GBX 395 million for the quarter. IXICO had a negative net margin of 24.98% and a negative return on equity of 16.18%. Equities research analysts anticipate that IXICO plc will post -289.3584879 EPS for the current year.

Insiders Place Their Bets

In other news, insider Mark Warne bought 50,006 shares of IXICO stock in a transaction that occurred on Wednesday, July 15th. The shares were purchased at an average price of GBX 8 per share, for a total transaction of £4,000.48. Insiders own 3.05% of the company’s stock.

About IXICO

IXICO is a global leader in neuroscience imaging and biomarker analytics, using its proprietary AI-driven platform to help advance the treatment of neurological disorders and reduce the uncertainties associated with drug discovery, development and monitoring.

By unlocking valuable insights into drug safety and efficacy, IXICO has built a global reputation and 20-year track record as an end-to-end Imaging Contract Research Organisation (iCRO) managing and analysing neurological clinical trials.